ID

37603

Descripción

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies; ODM derived from: https://clinicaltrials.gov/show/NCT02090543

Link

https://clinicaltrials.gov/show/NCT02090543

Palabras clave

Versiones (1)
  1. 10/8/19 10/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Atrial Fibrillation NCT02090543

Inglés

Eligibility Atrial Fibrillation NCT02090543

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
a.general criteria (group 1and group2):
Descripción

Criteria General

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0205246
diagnosed non-valvular af
Descripción

Atrial Fibrillation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004238
older than 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
general capability and willingness to perform a structured patient interview in german
Descripción

Patient interview German language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0683518
UMLS CUI [1,2]
C0017477
no participation in any other clinical or observational study over the last 3 month
Descripción

Participation Absent Clinical Trial Other | Participation Absent Observational Study Other

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205394
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C1518527
UMLS CUI [2,4]
C0205394
additional criteria for group1 (vka-experienced):
Descripción

Criteria Additional | Group Number

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1524062
UMLS CUI [2,1]
C0441833
UMLS CUI [2,2]
C0237753
active vka-therapy for at least 3 month without significant interruptions
Descripción

Vitamin K antagonists

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3653316
in case of perioperative interruption vka treatment should not have been hold for more than two weeks.
Descripción

Interruption perioperative | Vitamin K antagonists To be stopped

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512900
UMLS CUI [1,2]
C1518988
UMLS CUI [2,1]
C3653316
UMLS CUI [2,2]
C1272691
additional criteria for group2 (rivaroxaban-experienced patients):
Descripción

Criteria Additional | Group Number

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1524062
UMLS CUI [2,1]
C0441833
UMLS CUI [2,2]
C0237753
active rivaroxaban-therapy for at least 3 month without significant interruptions
Descripción

rivaroxaban

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1739768
in case of perioperative interruption vka treatment should not have been hold for more than two weeks.
Descripción

Interruption perioperative | Vitamin K antagonists To be stopped

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512900
UMLS CUI [1,2]
C1518988
UMLS CUI [2,1]
C3653316
UMLS CUI [2,2]
C1272691
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
participation in any other clinical or observational study over the last 3 month
Descripción

Study Subject Participation Status | Clinical Trial | Observational Study

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
UMLS CUI [3]
C1518527
Volver a la parte superior de la página

Similar models

Eligibility Atrial Fibrillation NCT02090543

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Criteria General
Item
a.general criteria (group 1and group2):
boolean
C0243161 (UMLS CUI [1,1])
C0205246 (UMLS CUI [1,2])
Atrial Fibrillation
Item
diagnosed non-valvular af
boolean
C0004238 (UMLS CUI [1])
Age
Item
older than 18 years
boolean
C0001779 (UMLS CUI [1])
Patient interview German language
Item
general capability and willingness to perform a structured patient interview in german
boolean
C0683518 (UMLS CUI [1,1])
C0017477 (UMLS CUI [1,2])
Participation Absent Clinical Trial Other | Participation Absent Observational Study Other
Item
no participation in any other clinical or observational study over the last 3 month
boolean
C0679823 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C0679823 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1518527 (UMLS CUI [2,3])
C0205394 (UMLS CUI [2,4])
Criteria Additional | Group Number
Item
additional criteria for group1 (vka-experienced):
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0441833 (UMLS CUI [2,1])
C0237753 (UMLS CUI [2,2])
Vitamin K antagonists
Item
active vka-therapy for at least 3 month without significant interruptions
boolean
C3653316 (UMLS CUI [1])
Interruption perioperative | Vitamin K antagonists To be stopped
Item
in case of perioperative interruption vka treatment should not have been hold for more than two weeks.
boolean
C1512900 (UMLS CUI [1,1])
C1518988 (UMLS CUI [1,2])
C3653316 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Criteria Additional | Group Number
Item
additional criteria for group2 (rivaroxaban-experienced patients):
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0441833 (UMLS CUI [2,1])
C0237753 (UMLS CUI [2,2])
rivaroxaban
Item
active rivaroxaban-therapy for at least 3 month without significant interruptions
boolean
C1739768 (UMLS CUI [1])
Interruption perioperative | Vitamin K antagonists To be stopped
Item
in case of perioperative interruption vka treatment should not have been hold for more than two weeks.
boolean
C1512900 (UMLS CUI [1,1])
C1518988 (UMLS CUI [1,2])
C3653316 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status | Clinical Trial | Observational Study
Item
participation in any other clinical or observational study over the last 3 month
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C1518527 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial